7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Prolactinomas in adolescent and elderly patients—A comparative long-term analysis

      research-article

      Read this article at

      ScienceOpenPublisherPMC
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Objectives

          Prolactinomas represent the most common type of secreting pituitary adenomas, yet are rarely encountered in adolescent-onset (AO; i.e. <18 years) or elderly-onset (EO; i.e. ≥65 years) cohorts. As a result, it is not clear whether long-term strategies should be focused differently at both age extremes when comparing their therapeutic outcomes. We aimed at investigating long-term endocrinological outcomes, looking for differences between the two cohorts and evaluating the dependence on continued dopamine agonist (DA) therapy.

          Methods

          Retrospective cross-sectional comparative study analyzing prolactinoma patients with a follow-up of ≥4 years. Clinical, radiological and biochemical characteristics were assessed at diagnosis and last follow-up. Longitudinal endocrinological outcomes between groups of extreme ages (i.e. AO and EO) and middle age (i.e. ≥18 years to 65 years) were compared. Independent risk factors for long-term dependence on DAs were calculated.

          Results

          Follow-up at ≥4 years was recorded for 108 prolactinoma patients; 10 patients with AO and 10 patients with EO. Compared to AO patients, EO patients were predominantly men ( p = 0.003), and presented with significantly higher prolactin (PRL) levels ( p = 0.05) and higher body mass index ( p = 0.03). We noted a significant positive correlation between patients' PRL values and their age (r = 0.5, p = 0.03) or BMI ( r = 0.6, p = 0.03). After a median follow-up of 115 months, remission was noted in 87 (83%) patients; 9 (90%) in AO patients, and 7 (70%) in EO patients ( p = 0.58). Continuation of DAs was required in 4 patients (40%) with AO and 7 patients (70%) with EO ( p = 0.37). Patients with elderly-onset were an independent predictor of long-term dependence on DAs (HR 2.8, 95% CI 1.1-7.2, p = 0.03).

          Conclusions

          Long-term control of hyperprolactinemia and hypogonadism does not differ between members of the AO and EO cohorts, and can be attained by the majority of patients. However, adjuvant DAs are often required, independent of the age of onset. Considering the clinical significance of persistent DA therapy for the control of hyperprolactinemia in many patients at both extremes of age, long-term monitoring may become recommended, in particular in patients with elderly-onset.

          Related collections

          Most cited references59

          • Record: found
          • Abstract: found
          • Article: not found

          Diagnosis and Treatment of Pituitary Adenomas

          Pituitary adenomas may hypersecrete hormones or cause mass effects. Therefore, early diagnosis and treatment are important.
            • Record: found
            • Abstract: found
            • Article: not found

            Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline.

            The aim was to formulate practice guidelines for the diagnosis and treatment of hyperprolactinemia. The Task Force consisted of Endocrine Society-appointed experts, a methodologist, and a medical writer. This evidence-based guideline was developed using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) system to describe both the strength of recommendations and the quality of evidence. One group meeting, several conference calls, and e-mail communications enabled consensus. Committees and members of The Endocrine Society, The European Society of Endocrinology, and The Pituitary Society reviewed and commented on preliminary drafts of these guidelines. Practice guidelines are presented for diagnosis and treatment of patients with elevated prolactin levels. These include evidence-based approaches to assessing the cause of hyperprolactinemia, treating drug-induced hyperprolactinemia, and managing prolactinomas in nonpregnant and pregnant subjects. Indications and side effects of therapeutic agents for treating prolactinomas are also presented.
              • Record: found
              • Abstract: found
              • Article: not found

              Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings.

              We present 25 pituitary adenomas that were confirmed surgically to have invaded the cavernous sinus space. The surgical results are compared with the preoperative magnetic resonance imaging findings. For comparable radiological criteria, we classified parasellar growth into five grades. This proposed classification is based on coronal sections of unenhanced and gadolinium diethylene-triamine-pentaacetic acid enhanced magnetic resonance imaging scans, with the readily detectable internal carotid artery serving as the radiological landmark. The anatomical, radiological, and surgical conditions of each grade are considered. Grades 0, 1, 2, and 3 are distinguished from each other by a medial tangent, the intercarotid line--through the cross-sectional centers--and a lateral tangent on the intra- and supracavernous internal carotid arteries. Grade 0 represents the normal condition, and Grade 4 corresponds to the total encasement of the intracavernous carotid artery. According to this classification, surgically proven invasion of the cavernous sinus space was present in all Grade 4 and Grade 3 cases and in all but one of the Grade 2 cases; no invasion was present in Grade 0 and Grade 1 cases. Therefore, the critical area where invasion of the cavernous sinus space becomes very likely and can be proven surgically is located between the intercarotid line and the lateral tangent, which is represented by our Grade 2. We also measured tumor growth rates, using the monoclonal antibody KI-67, which shows a statistically higher proliferation rate (P < 0.001) in adenomas with surgically observed invasion into the cavernous sinus space, as compared with noninvasive adenomas.

                Author and article information

                Contributors
                Journal
                Front Surg
                Front Surg
                Front. Surg.
                Frontiers in Surgery
                Frontiers Media S.A.
                2296-875X
                06 February 2023
                2023
                : 10
                : 967407
                Affiliations
                [ 1 ]Department of Neurosurgery, Kantonsspital Aarau , Aarau, Switzerland
                [ 2 ]Faculty of Medicine, University of Bern , Bern, Switzerland
                [ 3 ]Department of Gynecology and Obstetrics, Kantonsspital Lucerne , Lucerne, Switzerland
                [ 4 ]Department of Anaesthesiology and Pain Medicine, Inselspital, Bern University Hospital, University of Bern , Bern, Switzerland
                [ 5 ]Department of Neurosurgery, University Hospital of Basel , Basel, Switzerland
                [ 6 ]Department of Neurosurgery, Medical Center, University of Freiburg , Freiburg, Germany
                [ 7 ]Department of Endocrinology, Diabetes and Metabolism, University Hospital of Basel , Basel, Switzerland
                Author notes

                Edited by: Andrea Glezer, University of São Paulo, Brazil

                Reviewed by: Alberto Di Somma, Hospital Clinic of Barcelona, Spain Ekaterina Pigarova, Endocrinology Research Center, Russia

                [* ] Correspondence: Lukas Andereggen lukas.andereggen@ 123456dbmr.unibe.ch
                [ † ]

                ORCID Lukas Andereggen orcid.org/0000-0003-1764-688X

                Specialty Section: This article was submitted to Neurosurgery, a section of the journal Frontiers in Surgery

                Abbreviations BMI, body mass index; DA, dopamine agonists; IQR, interquartile range; n, numbers; PRL, prolactin (µg/L); TSS, transsphenoidal surgery; SD, standard deviation.

                Article
                10.3389/fsurg.2023.967407
                9939754
                36814862
                c58bb202-6a31-47b6-9d40-94348b4c9cdf
                © 2023 Andereggen, Tortora, Schubert, Musahl, Frey, Luedi, Mariani, Beck and Christ.

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 12 June 2022
                : 16 January 2023
                Page count
                Figures: 2, Tables: 3, Equations: 0, References: 61, Pages: 0, Words: 0
                Categories
                Surgery
                Original Research

                prolactinoma,dopamine agonists,age,surgery,long-term outcome

                Comments

                Comment on this article

                Related Documents Log